RC
EXEL icon

RegentAtlantic Capital’s Exelixis EXEL Stock Holding History

RegentAtlantic Capital’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-13,234
Closed -$233K – 436
2019
Q4 		$233K Sell
13,234
-1,925
-13% -$32.6K 0.01% 425
2019
Q3 		$268K Buy
15,159
+141
+0.9% +$2.85K 0.02% 383
2019
Q2 		$321K Sell
15,018
-982
-6% -$20.6K 0.02% 352
2019
Q1 		$381K Buy
16,000
+2,000
+14% +$45.6K 0.03% 323
2018
Q4 		$275K Sell
14,000
-50
-0.4% -$891 0.02% 351
2018
Q3 		$249K Buy
+14,050
New +$274K 0.02% 390

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

RegentAtlantic Capital's EXEL Position: Q1 2020 in Review

RegentAtlantic Capital sold out of Exelixis (EXEL) in Q1 2020, closing a stake of 13,234 shares — an estimated $233K sold.

RegentAtlantic Capital first reported a position in EXEL in Q3 2018 and held it in 6 quarters. The position peaked at $381K in Q1 2019. 336 funds tracked by Wall St. Rank hold EXEL as of Q1 2020.

  • RegentAtlantic Capital reported no remaining Exelixis position as of Q1 2020 after selling out during the quarter.
  • RegentAtlantic Capital sold 13,234 Exelixis shares in Q1 2020, an estimated $233K.
  • RegentAtlantic Capital first reported a position in Exelixis in Q3 2018 and held it in 6 quarters.
  • RegentAtlantic Capital's Exelixis position peaked at $381K in Q1 2019.
  • 336 funds tracked by Wall St. Rank held Exelixis as of Q1 2020.

Based on RegentAtlantic Capital's 13F filing for Q1 2020, filed 14 May 2020.